Back to search
Osteogenesis Imperfecta (OI)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta (OI) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Osteogenesis Imperfecta (OI) trials you may qualify forOsteogenesis Imperfecta-related hearing loss usually occurs in individuals with mild (type I) OI and is much earlier in onset than age-related hearing loss, wit…
This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo.
This prospective observational investigation will examine the incidence and progression of cardiologic findings in individuals with OI across different age grou…
This is a Phase 1/2 study to determine the safety and efficacy of allogeneic (third party), bone-marrow derived mesenchymal stromal cells (MSCs) for the treatme…
This study is to evaluate the safety and efficacy of AGA2115 at three different dose regimens in Chinese adults and adolescents with Type I, III, or IV Osteogen…
Osteogenesis imperfecta (OI) is a rare inherited disorder that causes bones to break easily. Individuals with osteogenesis imperfecta break bones often and may…